Rifampicin

Rifampicin is a pharmaceutical-grade active ingredient classified as a broad-spectrum Rifamycin Antibiotic. Mediocon Inc supplies high-purity Rifampicin API conforming to IP / BP / EP / USP specifications, manufactured in our GMP-certified facility in Aurangabad, Maharashtra, India.

Rifampicin (Rifampin) is a semisynthetic antibiotic derived from Amycolatopsis rifamycinica. It is a first-line antituberculosis drug and is also used in treatment of leprosy, brucellosis, Legionnaire's disease, and as prophylaxis for Meningococcal meningitis. It acts by inhibiting bacterial RNA polymerase, preventing transcription.

Key Features

• High-purity pharmaceutical grade API
• IP/BP/EP/USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• First-line tuberculosis treatment (DOTS regimen)
• Leprosy (dapsone combination therapy)
• Meningococcal meningitis prophylaxis
• Staphylococcal infections (with other antibiotics)

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings